Natural products in epilepsy-the present situation and perspectives for the future

Pharmaceuticals

Volumn 3, Issue 5, 2010, Pages 1426-1445

  Ekstein, Dana ^a   Schachter, Steven C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Botanicals; Complementary and alternative medicine (CAM); Epilepsy; Natural products

Indexed keywords

FISH OIL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; HYPERICUM PERFORATUM EXTRACT; LINSEED OIL; NATURAL PRODUCT; OMEGA 3 FATTY ACID;

ALTERNATIVE MEDICINE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; ECHINACEA; EPILEPSY; ETHNIC DIFFERENCE; GINKGO BILOBA; GINSENG; HEALTH SURVEY; HUMAN; HYPERICUM PERFORATUM; MEDICAL RESEARCH; NONHUMAN; REVIEW; RISK FACTOR; SEIZURE; TREATMENT OUTCOME; TREND STUDY;

EID: 77954934920     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3051426     Document Type: Review

References (65)

1. Kwan, P.; Brodie, M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342, 314-319.
2. Kwan, P.; Arzimanoglou, A.; Berg, A.T.; Brodie, M.J.; Allen Hauser, W.; Mathern, G.; Moshe, S.L.; Perucca, E.; Wiebe, S.; French, J. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia 2009 [Epub ahead of print].
3. Engel, J., Jr.; Wiebe, S.; French, J.; Sperling, M.; Williamson, P.; Spencer, D.; Gumnit, R.; Zahn, C.; Westbrook, E.; Enos, B. Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society, American Association of Neurological Surgeons: parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003, 60, 538-547.
4. Choi, H.; Sell, R.L.; Lenert, L.; Muennig, P.; Goodman, R.R.; Gilliam, F.G.; Wong, J.B. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: A decision analysis. JAMA 2008, 300, 2497-2505.
5. Engel, J., Jr. Surgical treatment for epilepsy: too little, too late? JAMA 2008, 300, 2548-2550.
6. Boon, P.; Raedt, R.; de Herdt, V.; Wyckhuys, T.; Vonck, K. Electrical stimulation for the treatment of epilepsy. Neurotherapeutics 2009, 6, 218-227.
7. Schmidt, D. Drug treatment of epilepsy: Options and limitations. Epilepsy Behav. 2009, 15, 56-65.
8. National Institutes of Health in National Center for Complementary and Alternatice Medicine Home Page. http://nccam.nih.gov/.
9. Devinsky, O., Schachter, S.C.; Pacia, S. In Complementary and Alternative Therapies for Epilepsy. Demos Medical Pub.: New York, NY, USA, 2005.
10. Cheuk, D.K.; Wong, V. Acupuncture for epilepsy. Cochrane Database Syst. Rev. 2008,doi: 10.1002/14651858.CD005062.pub3.
11. Ramaratnam, S.; Sridharan, K. Yoga for epilepsy. Cochrane Database Syst. Rev. 2000,doi: 10.1002/14651858.CD001524.
12. Li, Q.; Chen, X.; He, L.; Zhou, D. Traditional Chinese medicine for epilepsy. Cochrane Database Syst. Rev. 2009, doi: 10.1002/14651858.CD006454.pub2.
13. Barnes, P.M.; Bloom, B.; Nahin, R.L. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Report 2008, 10(12), 1-23.
14. Nahin, R.L.; Barnes, P.M.; Stussman, B.J.; Bloom, B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl. Health Stat. Report 2009, (18), 1-14.
15. Melchart, D.; Linde, K.; Fischer, P.; Kaesmayr, J. Echinacea for preventing and treating the common cold. Cochrane Database Syst. Rev. 2000, (2), CD000530.
16. Linde, K.; Barrett, B.; Wolkart, K.; Bauer, R.; Melchart, D. Echinacea for preventing and treating the common cold. Cochrane Database Syst. Rev. 2006, (1), CD000530.
17. Patel, J.V.; Tracey, I.; Hughes, E.A.; Lip, G.Y. Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. Vasc. Health Risk Manag. 2009, 5, 801-810.
18. Marchioli, R.; Barzi, F.; Bomba, E.; Chieffo, C.; Di Gregorio, D.; Di Mascio, R.; Franzosi, M.G.; Geraci, E.; Levantesi, G.; Maggioni, A.P.; Mantini, L.; Marfisi, R.M.; Mastrogiuseppe, G.; Mininni, N.; Nicolosi, G.L.; Santini, M.; Schweiger, C.; Tavazzi, L.; Tognoni, G.; Tucci, C.; Valagussa, F.; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105, 1897-1903.
19. Macchia, A.; Levantesi, G.; Franzosi, M.G.; Geraci, E.; Maggioni, A.P.; Marfisi, R.; Nicolosi, G.L.; Schweiger, C.; Tavazzi, L.; Tognoni, G.; Valagussa, F.; Marchioli, R.; GISSI-Prevenzione Investigators. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur. J. Heart Fail. 2005, 7, 904-909.
20. Studer, M.; Briel, M.; Leimenstoll, B.; Glass, T.R.; Bucher, H.C. Effect of different antilipidemic agents and diets on mortality: A systematic review. Arch. Intern. Med. 2005, 165, 725-730.
21. Gidal, B.E.; Sheth, R.D.; Bainbridge, J.; Ramsay, E.; Welty, T.E.; Weatherford, K.J.; Gilliam, F.; Gallo, B.V.; Alldredge, B.K.; Montouris, G.D.; Belden, D.S.; Lenners, A. Alternative Medicine (AM) Use in Epilepsy: Results of a National, Multicenter Survey. Epilepsia 1999, 40, 107-108.
22. Peebles, C.T.; McAuley, J.W.; Roach, J.; Moore, J.L.; Reeves, A.L. Alternative Medicine Use by Patients with Epilepsy. Epilepsy Behav. 2000, 1, 74-77.
23. Sirven, J.I.; Drazkowski, J.F.; Zimmerman, R.S.; Bortz, J.J.; Shulman, D.L.; Macleish, M. Complementary/alternative medicine for epilepsy in Arizona. Neurology 2003, 61, 576-577.
24. Plunkett, M.V.; Klein, E.W.; Alldredge, B.K. Use of Complementary and Alternative Medicine Products by Persons with Epilepsy. Epilepsia 2004, 45, 148-149.
25. Easterford, K.; Clough, P.; Comish, S.; Lawton, L.; Duncan, S. The use of complementary medicines and alternative practitioners in a cohort of patients with epilepsy. Epilepsy Behav. 2005, 6, 59-62.
26. Liow, K.; Ablah, E.; Nguyen, J.C.; Sadler, T.; Wolfe, D.; Tran, K.D.; Guo, L.; Hoang, T. Pattern and frequency of use of complementary and alternative medicine among patients with epilepsy in the midwestern United States. Epilepsy Behav. 2007, 10, 576-582.
27. Murphy, S.M.; Rogers, A.; Hutchinson, M.; Tubridy, N. Counting the cost of complementary and alternative therapies in an Irish neurological clinic. Eur. J. Neurol. 2008, 15, 1380-1383.
28. Kaiboriboon, K.; Guevara, M.; Alldredge, B.K. Understanding herb and dietary supplement use in patients with epilepsy. Epilepsia 2009, 50, 1927-1932.
29. Waaler, P.E.; Blom, B.H.; Skeidsvoll, H.; Mykletun, A. Prevalence, classification, and severity of epilepsy in children in western Norway. Epilepsia 2000, 41, 802-810.
30. Gross-Tsur, V.; Lahad, A.; Shalev, R.S. Use of complementary medicine in children with attention deficit hyperactivity disorder and epilepsy. Pediatr. Neurol. 2003, 29, 53-55.
31. Yuncker, L.A.; Kerszberg, S.; Hunt, S.L.; Lehman, E.B.; Barron, T.F. The Use of Alternative/Complementary Therapies in Children with Epilepsy and other Neurologic Disorders. Epilepsia 2004, 45, 326-327.
32. Rhodes, P.J.; Small, N.; Ismail, H.; Wright, J.P. The use of biomedicine, complementary and alternative medicine, and ethnomedicine for the treatment of epilepsy among people of South Asian origin in the UK. BMC Complement Altern. Med. 2008, 8, 7.
33. Prus, N.; Grant, A.C. Patient beliefs about epilepsy and brain surgery in a multicultural urban population. Epilepsy Behav. 2010, 17, 46-49.
34. Cohen, M.H. Regulation, religious experience, and epilepsy: A lens on complementary therapies. Epilepsy Behav. 2003, 4, 602-606.
35. LaFrance, W.C., Jr.; Kanner, A.M.; Hermann, B. Psychiatric comorbidities in epilepsy. Int. Rev. Neurobiol. 2008, 83, 347-383.
36. Harms, S.L.; Eberly, L.E.; Garrard, J.M.; Hardie, N.A.; Bland, P.C.; Leppik, I.E. Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home. J. Am. Geriatr. Soc. 2005, 53, 1023-1028.
37. Ivetic, V.; Popovic, M.; Mimica-Dukic, N.; Barak, O.; Pilija, V. St. John's wort (Hypericum perforatum L.) and kindling epilepsy in rabbit. Phytomedicine 2002, 9, 496-499.
38. Borrelli, F.; Izzo, A.A. Herb-drug interactions with St John's wort (Hypericum perforatum): An update on clinical observations. AAPS J. 2009, 11, 710-727.
39. Hinnell, C.; Williams, J.; Metcalfe, A.; Patten, S.B.; Parker, R.; Wiebe, S.; Jette, N. Health status and health-related behaviors in epilepsy compared to other chronic conditions-A national population-based study. Epilepsia 2010, 51(5), 853-861
40. Peled, N.; Shorer, Z.; Peled, E.; Pillar, G. Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia 2001, 42, 1208-1210.
41. Spinella, M. Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects. Epilepsy Behav. 2001, 2, 524-532.
42. Eadie, M.J. Could valerian have been the first anticonvulsant? Epilepsia 2004, 45, 1338-1343.
43. Sheldon, S.H. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998, 351, 1254.
44. Puri,B.K. The safety of evening primrose oil in epilepsy. Prostaglandins Leukot Essent Fatty Acids 2007, 77, 101-103.
45. Zhang, Z.; Lian, X.Y.; Li, S.; Stringer, J.L. Characterization of chemical ingredients and anticonvulsant activity of American skullcap (Scutellaria lateriflora). Phytomedicine 2009, 16, 485-493.
46. Kiani, J.; Imam, S.Z. Medicinal importance of grapefruit juice and its interaction with various drugs. Nutr. J. 2007, 6, 33.
47. Zanoli, P.; Rivasi, M.; Zavatti, M.; Brusiani, F.; Baraldi, M. New insight in the neuropharmacological activity of Humulus lupulus L. J. Ethnopharmacol. 2005, 102, 102-106.
48. Taha, A.Y.; Ciobanu, F.A.; Saxena, A.; McIntyre Burnham, W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009, 14, 27-31.
49. Haller, C.A.; Meier, K.H.; Olson, K.R. Seizures reported in association with use of dietary supplements. Clin. Toxicol. (Phila) 2005, 43, 23-30.
50. Jain, S. Ayurveda: The ancient indian system of medicine. In Complementary and Alternative Therapies for Epilepsy; Devinsky, O.; Schachter, S.C.; Pacia, S., Eds. Demos Medical Pub.: New York, NY, USA, 2005; pp. 123-128.
51. Schachter, S.C.; Acevedo, C.; Acevedo, K.A.; Lai, C.; Diop, A.G. Complementary and alternative medical therapies. In Epilepsy: A Comprehensive Textbook,. 2nd ed.; Engel, J.; Pedley, T.A., Eds.; Wolters Kluwer/Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2008; pp. 1407-1414.
52. Wang, S.; Li, Y. Traditional chinese medicine. In Complementary and Alternative Therapies for Epilepsy; Devinsky, O.; Schachter, S.C.; Pacia, S., Eds.; Demos Medical Pub.: New York, NY, USA, 2005; pp. 177-182.
53. Millogo, A.; Kabore, J.; Traore, E.D.; Druet-Cabanac, M.; Preux, P.M. Sociocultural aspects of epilepsy in secondary school students in Bobo-Dioulasso (Burkina Faso). Rev. Neurol. (Paris) 2002, 158, 1186-1190.
54. Baskind, R.; Birbeck, G. Epilepsy care in Zambia: A study of traditional healers. Epilepsia 2005, 46, 1121-1126.
55. Moshi, M.J.; Kagashe, G.A.; Mbwambo, Z.H. Plants used to treat epilepsy by Tanzanian traditional healers. J. Ethnopharmacol. 2005, 97, 327-336.
56. Stafford, G.I.; Pedersen, M.E.; van Staden, J.; Jager, A.K. Review on plants with CNS-effects used in traditional South African medicine against mental diseases. J. Ethnopharmacol. 2008, 119, 513-537.
57. Pedersen, M.E.; Vestergaard, H.T.; Hansen, S.L.; Bah, S.; Diallo, D.; Jager, A.K. Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions. J. Ethnopharmacol. 2009, 121, 472-475.
58. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. http://www.fda.gov/ohrms/dockets/98fr/cf0441.pdf.
59. Garrard, J.; Harms, S.; Eberly, L.E.; Matiak, A. Variations in product choices of frequently purchased herbs: caveat emptor. Arch. Intern. Med. 2003, 163, 2290-2295.
60. Guidance for Industry. Botanical drug products. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070491.pdf.
61. Striano, P.; Striano, S. New and investigational antiepileptic drugs. Expert Opin. Investig. Drugs 2009, 18, 1875-1884.
62. Awad, R.; Ahmed, F.; Bourbonnais-Spear, N.; Mullally, M.; Ta, C.A.; Tang, A.; Merali, Z.; Maquin, P.; Caal, F.; Cal, V.; Poveda, L.; Vindas, P.S.; Trudeau, V.L.; Arnason, J.T. Ethnopharmacology of Q'eqchi' Maya antiepileptic and anxiolytic plants: Effects on the GABAergic system. J. Ethnopharmacol. 2009, 125, 257-264.
63. Sucher, N.J. Insights from molecular investigations of traditional Chinese herbal stroke medicines: Implications for neuroprotective epilepsy therapy. Epilepsy. Behav. 2006, 8, 350-362.
64. Bialer, M.; Johannessen, S.I.; Levy, R.H.; Perucca, E.; Tomson, T.; White, H.S. Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res. 2009, 83, 1-43.
65. Park, P.; Schachter, S.; Yaksh, T. Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats. Neurosci. Lett. 2010, 470, 6-9.